Literature DB >> 760598

Volatile metabolites and decomposition products of halothane in man.

J H Sharp, J R Trudell, E N Cohen.   

Abstract

The presence of two volatile halothane metabolites, 2-chloro-1,1,1-trifluoroethane (CF3CH2Cl) and 2-chloro-1,1-difluoroethylene (CF2CHCl), and a metabolite-decomposition product, 2-bromo-2-chloro-1,1-difluoroethylene (CF2CBrCl), were identified by gas chromatography-mass spectrometry in exhaled gases of 16 patients anesthetized with halothane in nonrebreathing, semiclosed and totally closed anesthesia circuits. No significant differences in concentrations of CF3CH2Cl and CF2CHCl were found relative to the anesthesia circuits used. CF2CBrCl could not be identified in the expired gases of patients anesthetized with a nonrebreathing circuit (Bain), but was present in gases recovered from both semiclosed and totally closed circuits. Under totally closed-circuit rebreathing conditions, the concentration of CF2CBrCl increased to 4-5 ppm, indicating significant breakdown of halothane by the soda lime. Possible pathways for formation of the two metabolites and the metabolite-decomposition product are presented, as well as clinical implications of these findings.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760598     DOI: 10.1097/00000542-197901000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  The mechanism of the suicidal reductive inactivation of microsomal cytochrome P-450 by halothane.

Authors:  M Manno; S Cazzaro; M Rezzadore
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 2.  Halothane hepatitis: what's new?

Authors:  M J Cousins
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

Review 3.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

5.  Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs; the effects of vitamin E.

Authors:  I Durak; T Güven; M Birey; H S Oztürk; O Kurtipek; M Yel; B Dikmen; O Canbolat; M Kavutcu; M Kaçmaz
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

6.  Plasma levels of vitamin E and lipoperoxide during paediatric anaesthesia.

Authors:  H Obara; N Maekawa; H Hoshina; O Tanaka; R Chuma; S Iwai; H Hisano; K Nakamura; T Yamamoto
Journal:  Can Anaesth Soc J       Date:  1985-07

7.  Model studies in cytochrome P-450-mediated toxicity of halogenated compounds: radical processes involving iron porphyrins.

Authors:  D Brault
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

8.  Prospective study of liver function following repeat halothane and enflurane.

Authors:  J W Dundee; P D McIlroy; J P Fee; G W Black
Journal:  J R Soc Med       Date:  1981-04       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.